Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma Article

cited authors

  • George, Saby; Dreicer, Robert; Au, Jessie J. L.; Shen, Tong; Rini, Brian I.; Roman, Susan; Cooney, Matthew M.; Mekhail, Tarek; Elson, Paul; Wientjes, Guillaume M.; Ganapathi, Ram; Bukowski, Ronald M.

authors

Publication Date

  • September 1, 2008

webpage

published in

category

keywords

  • dose-limiting toxicity
  • fibroblast growth factor
  • pharmacokinetics
  • plasma concentration

start page

  • 79

end page

  • 85

volume

  • 6

issue

  • 2